Autres langues Nanjing Vazyme Biotech Co.,Ltd

Actions

688105

CNE100004ZK3

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
21,65 ^CNY	-0,96 %		-5,91 %	-32,39 %

26/04	Nanjing Vazyme Biotech Co, Ltd publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
15/04	Les actions chinoises augmentent après l'adoption de nouvelles lignes directrices ; les actions de Hong Kong chutent	RE

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Nanjing Vazyme Biotech Unit Gets Nod to Register Six Medical Devices; Shares Slump 14%	15/04
China stocks rise after new guidelines; HK shares drop	15/04
Nanjing Vazyme Biotech Swings to Loss in 2023	29/02
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Nanjing Vazyme Biotech Co.,Ltd announces an Equity Buyback for CNY 160 million worth of its shares.	06/02
Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.	05/02
Tranche Update on Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback Plan announced on August 22, 2023.	24/11
Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback announced on August 22, 2023, has closed with 618,077 shares, representing 0.15% for CNY 20.01 million.	24/11
Certain A Shares of Nanjing Vazyme Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 15-NOV-2023.	15/11
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Nanjing Vazyme Biotech Co.,Ltd(XSSC:688105) added to S&P Global BMI Index	18/09/23
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Nanjing Vazyme Biotech Plans Up to 30 Million Yuan Share Buyback	22/08/23
Nanjing Vazyme Biotech Co.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares.	22/08/23
Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.	21/08/23
Nanjing Vazyme Biotech Co., Ltd.(SHSE:688105) added to Shanghai Stock Exchange Health Care Sector Index	12/06/23
Vazyme Signs Global Strategic Cooperation Agreement with Azenta	31/05/23
Vazyme Biotech Registers New Pneumonia Pathogen Detection Kit	23/05/23
Nanjing Vazyme Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Nanjing Vazyme Biotech Co.,Ltd

Actions

688105

CNE100004ZK3

Autres langues

Filtres